Top compounds associated with response to FBXL2


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CTRPv2 pan-cancer AAC -0.11 0.002
mRNA SN-38 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.11 0.002
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.12 0.003
mRNA parbendazole CTRPv2 pan-cancer AAC -0.11 0.003
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA MS-275 CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV